Last updated on August 2019

A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis.

Clinical Study Identifier: NCT03435081

Find a site near you

Start Over

Kingsway Clinical Research

Etobicoke, ON Canada
  Connect »